메뉴 건너뛰기




Volumn 37, Issue 4, 2000, Pages 344-348

A 75-year-old Type 2 Diabetes Mellitus Case Responding Strikingly Troglitazon: Possible Mechanism of Insulin Resistance Induced by Insulin Antibody

Author keywords

Elderly diabetes mellitus; Insulin resistance; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CHROMAN DERIVATIVE; INSULIN ANTIBODY; THIAZOLE DERIVATIVE; TROGLITAZONE;

EID: 0034166913     PISSN: 03009173     EISSN: None     Source Type: Journal    
DOI: 10.3143/geriatrics.37.344     Document Type: Article
Times cited : (3)

References (6)
  • 1
    • 0026572747 scopus 로고
    • Pathogenesis of type 2 (non-insulin dependent) diadetes mellitus: a balanced overview
    • DeFonzo RA: Pathogenesis of type 2 (non-insulin dependent) diadetes mellitus: a balanced overview. Diade-tologia 1992; 35: 389–397.
    • (1992) Diade-tologia , vol.35 , pp. 389-397
    • DeFonzo, R.A.1
  • 2
    • 0029995670 scopus 로고    scopus 로고
    • Thiazolidinediones in the treatment of insulin resistance and type II diabetes
    • Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45: 1661–1669.
    • (1996) Diabetes , vol.45 , pp. 1661-1669
    • Saltiel, A.R.1    Olefsky, J.M.2
  • 3
    • 0018169688 scopus 로고
    • Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity in vivo
    • Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, et al.: Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 1978; 27: 1449–1452.
    • (1978) Metabolism , vol.27 , pp. 1449-1452
    • Harano, Y.1    Hidaka, H.2    Takatsuki, K.3    Ohgaku, S.4    Haneda, M.5    Motoi, S.6
  • 4
    • 0030033508 scopus 로고    scopus 로고
    • Effect of troglitazone. A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy
    • Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T: Effect of troglitazone. A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 1996; 19: 151–156.
    • (1996) Diabetes Care , vol.19 , pp. 151-156
    • Iwamoto, Y.1    Kosaka, K.2    Kuzuya, T.3    Akanuma, Y.4    Shigeta, Y.5    Kaneko, T.6
  • 5
    • 0030012267 scopus 로고    scopus 로고
    • Effect of combination therapy of troglitazone and sulfonyl ureas in patients with type 2 diabetes who were poorly controlled by sulfonylures therapy alone
    • Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T: Effect of combination therapy of troglitazone and sulfonyl ureas in patients with type 2 diabetes who were poorly controlled by sulfonylures therapy alone. Diabetic Medicine 1996; 13: 365–370.
    • (1996) Diabetic Medicine , vol.13 , pp. 365-370
    • Iwamoto, Y.1    Kosaka, K.2    Kuzuya, T.3    Akanuma, Y.4    Shigeta, Y.5    Kaneko, T.6
  • 6
    • 0032568310 scopus 로고    scopus 로고
    • Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
    • Schwartz S, Raskin P, Fonseca V, Graveline JF: Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. N Engl J Med 1998; 338: 861–866.
    • (1998) N Engl J Med , vol.338 , pp. 861-866
    • Schwartz, S.1    Raskin, P.2    Fonseca, V.3    Graveline, J.F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.